Progress in gene therapy for neurological disorders-Reference-Cited by-同舟云学术

Progress in gene therapy for neurological disorders

Published:2013-04-23 Issue:5 Volume:9 Page:277-291
ISSN:1759-4758
Container-title:Nature Reviews Neurology
language:en
Short-container-title:Nat Rev Neurol

Author:

Simonato Michele,Bennett Jean,Boulis Nicholas M.,Castro Maria G.,Fink David J.,Goins William F.,Gray Steven J.,Lowenstein Pedro R.,Vandenberghe Luk H.,Wilson Thomas J.,Wolfe John H.,Glorioso Joseph C.

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology (clinical)

Link

http://www.nature.com/articles/nrneurol.2013.56.pdf

Reference155 articles.

1. Elsabahy, M., Nazarali, A. & Foldvari, M. Non-viral nucleic acid delivery: key challenges and future directions. Curr. Drug Deliv. 8, 235–244 (2011).

2. Goncalves, M. A. Adeno-associated virus: from defective virus to effective vector. Virol. J. 2, 43 (2005).

3. Matrai, J., Chuah, M. K. & VandenDriessche, T. Recent advances in lentiviral vector development and applications. Mol. Ther. 18, 477–490 (2010).

4. Nayak, S. & Herzog, R. W. Progress and prospects: immune responses to viral vectors. Gene Ther. 17, 295–304 (2010).

5. Foust, K. D. et al. Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat. Biotechnol. 27, 59–65 (2009).

Cited by 204 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoparticle-based Gene Therapy for Neurodegenerative Disorders;Mini-Reviews in Medicinal Chemistry;2024-10

2. Biofluid specific protein coronas affect lipid nanoparticle behavior in vitro;Journal of Controlled Release;2024-09

3. Neurosurgical gene therapy for central nervous system diseases;Neurotherapeutics;2024-07

4. Stem cell therapeutics and gene therapy for neurologic disorders;Neurotherapeutics;2024-07

5. Developing AAV-delivered nonsense suppressor tRNAs for neurological disorders;Neurotherapeutics;2024-07